Literature DB >> 11819642

Induction of apoptosis by arsenic trioxide and hydroxy camptothecin in gastriccancer cells in vitro.

Shui-Ping Tu, Jie Zhong, Ji-Hong Tan, Xiao-Hua Jiang, Min-Min Qiao, Yu-Xin Wu, Shi-Hu Jiang.   

Abstract

AIM:To study the effects of arsenic trioxide and HCPT on dif ferent degrees of differentiated gastric cancer cells (SGC-7901, MKN-45, MKN-28) with respect to both cytotoxicity and induction of apoptosis in vitro.
METHODS: The cytotoxicity of As(2)O(3) and HCPT on gastric cancer cells was det ermined by MTT assay.Morphologic changes of apoptosis of gastric cancer cells were observed by light microscopy and transmission electron microscopy.Apoptosis and cell cycle changes of gastric cancer cells induced by HCPT and As(2)O(3) we re investigated by TUNEL method and flow cytometry.
RESULTS: As(2)O(3) and HCPT had remarkable cytotoxic effects on different degrees of differentiated gastric cancer cells. The IC(50) of As(2)O(3) on well differentiated gastric cancer cell MKN-28, moderately differentiated gastric cancer cell SGC-7901, and poorly differentiated gastric cancer cell MKN-28 were 8.91 &mgr;mol/L, 10.57 &mgr;mol/L, and 11.65&mgr;mol/L, respectively. The IC(50) of HCP T on MKN-28, SGC-7901, and MKN-45 were 9.35 mg/L, 10.21 mg/L,and 12.63 mg/L respectively after 48 h treatment. After 12 h of exposure to both drugs, gastric cancer cells exhibited morphologic features of apoptosis, includ ing cell shrinkage,nuclear condensation, and formation of apoptotic bodies. A ty pical subdiploid peak before G(0)/G(1) phase was observed by flow cytometry. The apoptotic rates of SGC-7901, MKN-45, and MKN-28 were 13.84%, 22.52%, and 9.68%, respectively after48 h exposure to 10&mgr;mol/L As(2)O(3). The apoptotic ra tes of SGC-7901, MKN-45, and MKN-28 were 21.88%, 12.35%, and 30.26%, resp ectively after 48 h exposure to 10 mg/L HCPT. The apoptotic indice were 7%-15% a s assessed by TUNEL method. The effect of As(2)O(3) on SGC-7901 showed remarkab le cell cycle specificity, which induced cell death in G(1) phase, and blocked G(2)/M phase.HCPT also showed a remarkable cell cycle specificity, by inducing cell death and apoptosis in G(1) phase and arrest of proliferation at Sphase.
CONCLUSION: As(2)O(3) and HCPT exhibit significant cytotoxicity on gastric canc er cells by induction of apoptosis. As(2)O(3) and HCPT might have a promising pr ospect in the treatment of gastric cancer, which needs to be further studied.

Entities:  

Year:  2000        PMID: 11819642      PMCID: PMC4723552          DOI: 10.3748/wjg.v6.i4.532

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  [The mechanisms of arsenic trioxide-induced apoptosis in hematopoietic malignant cells].

Authors:  X Cai; G Chen; P Jia
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1999-06

2.  Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death.

Authors:  A T Sané; R Bertrand
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

3.  Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein.

Authors:  Y Akao; H Mizoguchi; S Kojima; T Naoe; N Ohishi; K Yagi
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

4.  [10-Hydroxycamptothecin induces apoptosis in human T24 urinary bladder cancer cells].

Authors:  J Fan; X Tang; X Zhang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1998-04

5.  In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.

Authors:  G Q Chen; J Zhu; X G Shi; J H Ni; H J Zhong; G Y Si; X L Jin; W Tang; X S Li; S M Xong; Z X Shen; G L Sun; J Ma; P Zhang; T D Zhang; C Gazin; T Naoe; S J Chen; Z Y Wang; Z Chen
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

6.  Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.

Authors:  P Rousselot; S Labaume; J P Marolleau; J Larghero; M H Noguera; J C Brouet; J P Fermand
Journal:  Cancer Res       Date:  1999-03-01       Impact factor: 12.701

7.  The pro-apoptotic drug camptothecin stimulates phospholipase D activity and diacylglycerol production in the nucleus of HL-60 human promyelocytic leukemia cells.

Authors:  A M Martelli; R Bortul; R Bareggi; G Tabellini; V Grill; G Baldini; P Narducci
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

8.  Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.

Authors:  G K Schwartz; A Haimovitz-Friedman; S K Dhupar; D Ehleiter; P Maslak; L Lai; F Loganzo; D P Kelsen; Z Fuks; A P Albino
Journal:  J Natl Cancer Inst       Date:  1995-09-20       Impact factor: 13.506

9.  Effects of arsenic on DNA damage and repair in human fetal lung fibroblasts.

Authors:  J T Dong; X M Luo
Journal:  Mutat Res       Date:  1994-07       Impact factor: 2.433

10.  A dual topoisomerase inhibitor, TAS-103, induces apoptosis in human cancer cells.

Authors:  T Ohyama; Y Li; T Utsugi; S Irie; Y Yamada; T Sato
Journal:  Jpn J Cancer Res       Date:  1999-06
View more
  20 in total

1.  Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma.

Authors:  W Wang; S K Qin; B A Chen; H Y Chen
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  The effects of vitamin E succinate on the expression of c-jun gene and protein in human gastric cancer SGC-7901 cells.

Authors:  Yan Zhao; Kun Wu; Wei Xia; Yu-Juan Shan; Li-Jie Wu; Wei-Ping Yu
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells.

Authors:  Zhi-Su Liu; Sheng-Li Tang; Zhong-Li Ai
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

4.  Experimental study on ultrasound-guided intratumoral injection of "Star-99" in treatment of hepatocellular carcinoma of nude mice.

Authors:  Li-Wu Lin; Xiao-Dong Lin; Yi-Mi He; Shang-Da Gao; En-Sheng Xue
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  Roles of Fas signaling pathway in vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells.

Authors:  Kun Wu; Yao Li; Yan Zhao; Yu-Juan Shan; Wei Xia; Wei-Ping Yu; Lan Zhao
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

6.  Construction of expression systems for flaA and flaB genes of Helicobacter pylori and determination of immunoreactivity and antigenicity of recombinant proteins.

Authors:  Jie Yan; Shao-Hui Liang; Ya-Fei Mao; Li-Wei Li; Shu-Ping Li
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  Construction of hpaA gene from a clinical isolate of Helicobacter pylori and identification of fusion protein.

Authors:  Ya-Fei Mao; Jie Yan; Li-Wei Li; Shu-Ping Li
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  Construction of prokaryotic expression system of ureB gene from a clinical Helicobacter pylori strain and identification of the recombinant protein immunity.

Authors:  Ya-Fei Mao; Jie Yan
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

9.  Construction of a prokaryotic expression system of vacA gene and detection of vacA gene, VacA protein in Helicobacter pylori isolates and ant-VacA antibody in patients' sera.

Authors:  Jie Yan; Ya-Fei Mao
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

10.  Effects of vitamin E succinate on the expression of Fas and PCNA proteins in human gastric carcinoma cells and its clinical significance.

Authors:  Kun Wu; Lan Zhao; Yao Li; Yu-Juan Shan; Li-Jie Wu
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.